Certified by Founder Lodge
Solu Therapeutics
United States - Boston , MA
START UP
1 Disclosed Funding Rounds $31,000,000
0 Participating Investments
-
Founded date
2023
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Solu Therapeutics is a precision-medicine focused company developing therapeutics to eliminate cells that drive oncologic, inflammatory, and autoimmune diseases.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| August, 01 ,2023 | Seed | $31,000,000 |
Alexandria Real Estate Equities, Inc.
SANTÉ
DCVC Bio
Longwood Fund
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Insider. | $500,000,000 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
